178 results
8-K
EX-4.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest … price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
8-K
EX-4.3
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith … Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding
8-K
EX-4.2
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest … price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
424B3
wylf 93ni4879kqgj
2 Feb 24
Prospectus supplement
12:00am
DEF 14C
kfb lu1pwm08kpb07
29 Jan 24
Information statement
8:00am
PRE 14C
pqxb8
17 Jan 24
Preliminary information
5:05pm
8-K
EX-4.2
o0aaqi27c51
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.1
mcopn
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.3
7qnnup iipaq3xsn5
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
3eo4tzcpq
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.2
x2c6gitttwq kxim
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm